Try our Advanced Search for more refined results

Expert Analysis

What Cannabis Patent Applicants Can Learn From Biopharma

By Pauline Pelletier and Deborah Sterling ( January 17, 2019, 12:48 PM EST) -- Today the cannabis industry is booming and analysts have projected that it will grow from $9.2 billion in 2017 to $47.3 billion in 2027 in North America alone.[1] This past year saw the first U.S. Food and Drug Administration-approved drug comprised of an active ingredient derived from cannabis.[2] It also saw the first patent infringement suit involving a cannabis-related patent.[3] And in just the first month of 2019 we have seen the first decision in a post-grant proceeding involving a cannabis-related patent[4] as well as legislation for legalizing and regulating cannabis introduced in the House of Representatives.[5]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!